May 2023
2023
21/05/2023
Heartbreaking impact of endometriosis on women laid bare – The West Australian
18/05/2023
Video Interview – Exclusive Agreement with Sonic Healthcare USA
10/05/2023
Proteomics International & Sonic Healthcare USA sign exclusive licence agreement
10/05/2023
Proteomics seals exclusive deal for kidney test in US – The West Australian
10/05/2023
Proteomics International (ASX:PIQ) inks exclusive licence agreement to bring PromarkerD to the US market – The Market Herald
10/05/2023
Proteomics’ PromarkerD test enters the lucrative US market – THE SENTIMENT
10/05/2023
May Newsletter 2023
05/05/2023
New diagnostic blood test showcased at world’s premier endometriosis conference
03/05/2023
PromarkerD test scores show treatment with canagliflozin can lessen risk of diabetic kidney disease
Newsroom
News Archive
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
Subscribe
Title
Name
*
Position
Company/Organisation
*
Phone
Email
*
Terms & Conditions
*
I accept the terms and conditions
Email
This field is for validation purposes and should be left unchanged.
Company
About Us
Mission Statement
Senior Staff
Board of Directors
Clinical Advisory Board
Customer Testimonials
Quality Control
Careers
Glossary
Promarker™ Pipeline
PromarkerD
PromarkerEndo
PromarkerEso
OxiDx
Project Statuses
Biomarker Discovery
Analytical Services
Pharmacokinetics
Biomarker Services
Protein Analysis
Project Consultation
Pricing and Ordering – Commercial
Pricing and Ordering - Local WAP
Downloads
Terms and Conditions
FAQs
Newsroom
News & Media
Newsletters
Publications
Events and Presentations
Investors
ASX Announcements
Share Price and Analyst Coverage
Library
Reports
Corporate Governance
Shareholder Information
Annual General Meeting
Contact
Sample Delivery
Technical
Business Development
Agents
